Financial insights of OMER

MyFinsight

For the year ending 2025-12-31.

Income Statement	2025-12-31
Research and development	81,296
Selling, general and administrative	41,500
Total costs and expenses	122,796
Loss from operations	-122,796
Gain on sale of zaltenibart	237,594
Gain on early extinguishment of debt-Initial Term Loan	17,035
Gain on early extinguishment of debt-Convertible Senior Notes2026	-2,968
Interest and other income	4,096
Interest expense, net of remeasurement adjustments and other	-960
Gain (loss) on change in fair value of financial instruments, net	-136,717
Loss from continuing operations before income tax expense	-2,796
Income tax expense	2,012
Net loss from continuing operations, net of tax	-4,808
Net income from discontinued operations, net of tax	1,458
Net loss	-3,350

Basic EPS	-0.05
Diluted EPS	-0.05
Basic Average Shares	63,510,201

Unit: Thousand (K) dollars (except for numbers of shares and EPS).